JPH01223970A - Substitute bone - Google Patents

Substitute bone

Info

Publication number
JPH01223970A
JPH01223970A JP63050280A JP5028088A JPH01223970A JP H01223970 A JPH01223970 A JP H01223970A JP 63050280 A JP63050280 A JP 63050280A JP 5028088 A JP5028088 A JP 5028088A JP H01223970 A JPH01223970 A JP H01223970A
Authority
JP
Japan
Prior art keywords
bone
substitute
base member
porous layer
inorg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63050280A
Other languages
Japanese (ja)
Inventor
Toru Araya
徹 新家
Hiroshi Yamashita
浩志 山下
Kenji Doi
憲司 土居
Yoshio Sasaki
佐々木 佳男
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kobe Steel Ltd
Original Assignee
Kobe Steel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobe Steel Ltd filed Critical Kobe Steel Ltd
Priority to JP63050280A priority Critical patent/JPH01223970A/en
Publication of JPH01223970A publication Critical patent/JPH01223970A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

PURPOSE:To form strong bonding to a residual own bone at an early stage and to fix a substitute bone strongly over a long period of time, by providing a porous layer coated with an biologically active inorg. material to the surface of a base member on the contact side with the residual own bone thereof. CONSTITUTION:A porous layer 5 coated with a biologically active inorg. material 6 is provided to a base member 8 and formed so as to be exposed on the contact side with the own bone in such a state that the base member 8 is engaged with a substitute bone main body 1'. When the bone omitted part of a living body is filled with this inventive substitute bone 1, the chemical bonding between the biologically active inorg. material 6 and the own bone 2 is rapidly advanced and, further, an osteoblast penetrates into the fine voids of the porous layer 5 with the elapse of time and the new bone formed therein acts like an anchor to strongly fix the substitute bone 1 and the own bone 2.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は生体の骨欠損部を補填する為の代替骨に関する
ものであって、残存自家骨に対して早期に強力な結合を
形成し、しかも長期に亘ってしっかりと固定される様な
代替骨に関するものである。
[Detailed Description of the Invention] [Industrial Application Field] The present invention relates to a substitute bone for filling bone defects in a living body, which forms a strong bond to the remaining autologous bone at an early stage, Moreover, it relates to a substitute bone that can be firmly fixed over a long period of time.

[従来の技術] 事故や疾病あるいは抜歯等により骨損傷を来した場合、
骨欠損部あるいは空隙部への充填が必要となる。
[Conventional technology] When bone damage occurs due to an accident, illness, tooth extraction, etc.
Filling of bone defects or voids is required.

このような場合、別個法由来の生体骨を移植すると免疫
の拒否反応を起こすので、患者本人の肋骨や腰骨から海
綿状自家骨を採取して欠損部に充填する方法がとられて
きた。しかしこの方法では損傷個所以外の骨組織を切除
することになるので手術個所が増加して患者の苦痛も大
きく、医師側にとっても多大の労力を必要としていた。
In such cases, transplanting living bone derived from a separate method would cause an immune rejection reaction, so methods have been taken in which cancellous autologous bone is harvested from the patient's own ribs or hip bones and filled into the defect. However, this method requires removal of bone tissue other than the damaged area, which increases the number of surgical sites, causes great pain for the patient, and requires a great deal of labor on the part of the doctor.

しかも採取できる個所や量に制限があるので、必ずしも
十分に欠損部を補填し得る量を採取できるわけではなく
、代替骨の必要が生じていた。
Moreover, since there are restrictions on the location and amount that can be harvested, it is not always possible to harvest enough bone to compensate for the defect, creating the need for substitute bone.

このような代替骨は補填箇所に応じた強度を有すると共
に生体に対して無害であることはいうまでもなく、自家
骨に早期に且つしっかり固定され長期使用に亘ってゆる
みなどが生じてはならない。
It goes without saying that such bone substitutes have strength commensurate with the replacement site and are harmless to living organisms, and they must be able to be quickly and firmly fixed to the autologous bone and not loosen over long-term use. .

たとえば人工股関節ステムは長期間に亘る安定した強度
を確保するためステンレス鋼、C〇−Cr合金あるいは
チタン合金等の耐食性金属で製造されているが、この様
な金属製股関節ステムを生体骨に固定するに当たっては
、たとえば次のような手段がとられている。
For example, artificial hip joint stems are manufactured from corrosion-resistant metals such as stainless steel, C-Cr alloy, or titanium alloy to ensure stable strength over long periods of time. For example, the following measures are taken:

(1)セメント固定:第3図(a)に示すように自家骨
2の骨髄腔内に代替骨(股関節ステム)1の支え部1a
を挿入し、骨髄腔と代替骨1の支え部1aの隙間にポリ
メチルメタクリレート等よりなる骨セメント7を充填し
て固定させる。
(1) Cement fixation: As shown in Fig. 3(a), the supporting part 1a of the substitute bone (hip stem) 1 is placed in the medullary cavity of the autologous bone 2.
is inserted, and the gap between the bone marrow cavity and the supporting portion 1a of the substitute bone 1 is filled with bone cement 7 made of polymethyl methacrylate or the like and fixed.

(2)セメントレス固定:第3図(b)に示すように代
替骨1の支え部1aを自家骨2の骨髄腔に密嵌合するよ
うな太さに形成し両者を密嵌合させて機械的に固定させ
る。
(2) Cementless fixation: As shown in Fig. 3(b), the supporting portion 1a of the substitute bone 1 is formed to a thickness that fits tightly into the medullary cavity of the autologous bone 2, and the two are tightly fitted. Fix mechanically.

ところが前記(1)の方法は言うに及ばず(2)の方法
に、おいても、代替骨1と自家骨2の間に金属−自家骨
の直接結合が形成される訳ではないので、長時間経過す
るとゆるみが生じてくるほか、(1)の方法ではセメン
トの重合熱や成分溶出を原因とする生体への悪影響を生
ずるといった問題を有していた。
However, in method (2) as well as in method (1), a direct bond between metal and autologous bone is not formed between substitute bone 1 and autologous bone 2; In addition to loosening over time, method (1) also has the problem of adverse effects on living organisms due to polymerization heat of cement and component elution.

これらの問題を解決するためにまずセメント固定法を排
除すると共にセメントレス固定法の上記欠点を改善する
ことが研究されている。この様な改善方法として例えば
第4図(a) 、 (b)およびその表層部の断面図(
c) 、 (d)に示すように、代替骨1の自家骨2と
の接触側表層部に金属製の粒体3または金属製の繊維4
を巻縮するように配置するかあるいは金属製の繊維4の
編物、織物、不織布を配置して代替骨1の表面にポーラ
ス層5を形成するという方法が行なわれており、この方
法によれば残存自家骨から成長してくる骨芽細胞が該ポ
ーラス層5の微細空隙内に侵入し、新生骨によるアンカ
ー効果によって自家骨2と代替骨1の固定を達成する。
In order to solve these problems, research has been conducted to eliminate the cement fixation method and to improve the above-mentioned drawbacks of the cementless fixation method. Examples of such improvement methods include Figures 4(a) and 4(b) and a cross-sectional view of the surface layer (
c) As shown in (d), metal granules 3 or metal fibers 4 are placed on the surface layer of the substitute bone 1 on the side that is in contact with the autologous bone 2.
According to this method, a porous layer 5 is formed on the surface of the substitute bone 1 by arranging the metal fibers 4 so as to be crimped or by arranging knitted, woven, or nonwoven fabrics of metal fibers 4. Osteoblasts growing from the remaining autologous bone invade into the microscopic voids of the porous layer 5, and fixation of the autologous bone 2 and substitute bone 1 is achieved by the anchoring effect of the new bone.

しかしこの方法では新生骨が代替骨のポーラス層の深奥
部へ侵入生成するまでに時間がかかり、代替骨が自家骨
に固定されるまでに長時間を要した。
However, with this method, it took time for new bone to penetrate deep into the porous layer of the substitute bone, and it took a long time for the substitute bone to be fixed to the autologous bone.

[発明が解決しようとする課題] そこで本発明においては代替骨を自家骨欠損部の補填に
適用する場合において自家骨との結合が速やかに進行し
、しかも時間経過とともに強固な固着に成長し、長期使
用に亘っでもゆるみなどの生じてとない代替骨について
検討した。
[Problems to be Solved by the Invention] Accordingly, in the present invention, when a substitute bone is applied to compensate for an autologous bone defect, the bone substitute rapidly integrates with the autologous bone, and grows into a strong fixation over time. We investigated bone substitutes that do not loosen even after long-term use.

[課題を解決するための手段] 上記課題を解決することのできた本発明とは、骨欠損部
補填用の代替骨において、該代替骨に形成された貫通孔
あるいは凹部にベース部材を嵌着させて構成すると共に
、前記ベース部材の残存自家骨との接触側表面に生体活
性無機材料によって被覆されているポーラス層が設けら
れていることを構成要旨とするものである。
[Means for Solving the Problems] The present invention that has solved the above problems is a bone substitute for filling a bone defect, in which a base member is fitted into a through hole or a recess formed in the bone substitute. The gist of the structure is that a porous layer coated with a bioactive inorganic material is provided on the surface of the base member that comes into contact with the remaining autologous bone.

[作用] 第1図(a)〜(c)は本発明に係る代替骨1の実施態
様例を示す図であり、(d)はその組立て構成例を示す
図である。第1図(d)に示すように本発明の代替骨1
は、貫通孔あるいは凹部(図示せず)を有する代替骨本
体1°に前記貫通孔(あるいは凹部)に嵌合する形状に
形成されたベース部材8を嵌着させて構成される。ベー
ス部材8には第1図(e) 、 (f) 、 (g) 
、 (h)に示した表層部所面図に見られる如く生体活
性無機材料6によって被覆されているポーラス層5が設
けられており、該ポーラス層5は、ベース部材8を代替
骨本体1°に嵌着させた状態において自家骨と接触する
側に表われる様に形成される。生体骨欠損部を本発明の
代替骨1で補填すると、生体活性無機材料6と自家骨2
との間の化学的結合が速やかに進行し、さらに時間の経
過とともにたとえば第1図(e) 、 (f)ではポー
ラス層5の微細空隙内に骨芽細胞が侵入してゆき、そこ
で形成された新生骨がアンカーのように作用して代替骨
1と自家骨2をしっかり固定する。また第1図(g) 
、 (h)のように生体活性無機材料6よりなる層が厚
く形成されているときは生体活性無機材料6が自家骨2
と化学結合しつつ新生骨が深く侵入していき最終的に新
生骨が粒体3や繊維4の背面にまで侵入するのでアンカ
ー作用を発揮する。
[Operation] FIGS. 1(a) to 1(c) are diagrams showing an embodiment of the bone substitute 1 according to the present invention, and FIG. 1(d) is a diagram showing an example of its assembly configuration. As shown in FIG. 1(d), bone substitute 1 of the present invention
is constructed by fitting a base member 8 formed into a shape that fits into the through hole (or recess) into a substitute bone body 1° having a through hole or recess (not shown). The base member 8 is shown in Fig. 1 (e), (f), (g).
As shown in the top view of the surface layer shown in FIG. It is formed so that it appears on the side that comes into contact with the autologous bone when it is fitted into the bone. When a biological bone defect is filled with the substitute bone 1 of the present invention, the bioactive inorganic material 6 and the autologous bone 2
The chemical bond between the two rapidly progresses, and over time, for example, as shown in FIGS. The newly formed bone acts like an anchor and firmly fixes the substitute bone 1 and the autologous bone 2. Also, Figure 1 (g)
, When the layer made of the bioactive inorganic material 6 is formed thickly as shown in (h), the bioactive inorganic material 6 is attached to the autologous bone 2.
The new bone penetrates deeply while chemically bonding with the new bone, and finally the new bone penetrates into the back surface of the granules 3 and fibers 4, so that it exerts an anchoring effect.

本発明に係る代替骨本体1°の主体となる素材としては
金や銀等の貴金属、5US318等のステンレス鋼、T
i−6AI−4V等のチタン合金等の耐食性金属あるい
はアルミナ、ジルコニア。
The main materials of the substitute bone body 1° according to the present invention include precious metals such as gold and silver, stainless steel such as 5US318, and T.
Corrosion-resistant metals such as titanium alloys such as i-6AI-4V, alumina, and zirconia.

窒化けい素等の高強度セラミックス等を用いることがで
き、骨欠損部の形態に嵌合するように成形して適用する
High-strength ceramics such as silicon nitride can be used, and the material is molded to fit the shape of the bone defect.

ベース部材8の主体となる素材としては前記した代替骨
太体1゛と同様の素材を挙げることができ、代替骨本体
1°と同じであってもあるいは異なる素材を用いてもよ
い。
The main material of the base member 8 can be the same material as that of the above-mentioned substitute bone body 1', and may be the same as or different from the material of the substitute bone body 1'.

生体活性無機材料6を被覆したポーラス層5とは、粒径
100〜800μm1好ましくは300〜600μmの
金属やセラミックス等よりなる粒体3をベース部材8の
表面の一部に多数拡散接合するか、直径100〜800
μmの繊維を屈曲させて前記表面の一部にランダム配位
し拡散接合したり、或は繊維よりなる編・織物や不織布
を前記表面の一部に配位して拡散接合する等の手段によ
っであるいはベース部材−8の表面の一部を粗面化する
ことによって、孔径100〜500μmの孔を多数内在
するポーラス層を形成し、さらにその上へ生体活性無機
材料6を被覆して厚さ1〜100μmの層を形成させた
ものである。孔径が100μm未満では骨芽細胞の侵入
が不十分であり、500μmを超えると骨芽細胞の侵入
によって生成される新生骨の形成に時間がかかるととも
にアンカー作用が不十分となる。孔径100〜500μ
mの孔を有するポーラス層を形成する手段については特
別の制限を受けないが、前記した粒径100〜800μ
mの粒体3あるいは直径100〜800μmの繊維4を
前述のように拡散接合させる方法はもっとも有利な方法
と言える。
The porous layer 5 coated with the bioactive inorganic material 6 is formed by diffusion bonding a large number of particles 3 made of metal, ceramics, etc. with a particle size of 100 to 800 μm, preferably 300 to 600 μm, to a part of the surface of the base member 8, or Diameter 100-800
By bending fibers of μm and randomly arranging them on a part of the surface and performing diffusion bonding, or by arranging knitted, woven or non-woven fabrics made of fibers on a part of the surface and performing diffusion bonding, etc. Therefore, by roughening a part of the surface of the base member 8, a porous layer containing many pores with a pore diameter of 100 to 500 μm is formed, and the bioactive inorganic material 6 is further coated on top of the porous layer to form a thick layer. A layer with a thickness of 1 to 100 μm is formed. If the pore diameter is less than 100 μm, the invasion of osteoblasts will be insufficient, and if it exceeds 500 μm, it will take time to form new bone generated by the invasion of osteoblasts, and the anchoring effect will be insufficient. Pore diameter 100~500μ
There are no particular restrictions on the means for forming a porous layer having pores of
The most advantageous method is to diffusion-bond particles 3 with a diameter of m or fibers 4 with a diameter of 100 to 800 μm as described above.

尚こわらの粒体あるいは繊維の素材としては前述の代替
骨本体およびベース部材の素材と同様のものを用いるこ
とができ、代替骨本体およびベース部材と同一あるいは
異なっているものを用いても良い。
As the material for the stiff grains or fibers, the same materials as those for the substitute bone body and base member described above can be used, or the same or different materials as those for the substitute bone body and base member may be used. .

生体活性無機材料とは、生体内で周囲の骨組織と反応し
、自家骨との間に強い化学結合を形成する特性を有する
ものであり、例えばアパタイト類特に水酸化アパタイト
[Ca +o (PO4) a (0)1) 2] 、
アパタイトを含むアルミナあるいはジルコニアセラミッ
クス、β−3CaO−P20s 、 Na20−CaO
−5iO2−P20s系ガラス(バイオガラス)、第1
表に示す様な系のアパタイト含有結晶化ガラス等が例示
される。
Bioactive inorganic materials have the property of reacting with surrounding bone tissue in vivo and forming strong chemical bonds with autologous bone, such as apatites, especially hydroxyapatite [Ca + O (PO4)]. a (0)1) 2],
Alumina or zirconia ceramics containing apatite, β-3CaO-P20s, Na20-CaO
-5iO2-P20s glass (bioglass), 1st
Examples include apatite-containing crystallized glass as shown in the table.

アパタイト含有結晶化ガラスは結晶とガラスの複合体で
あり、結晶の大きさや量あるいは組成を連続的に変化さ
せることができてその性質を広い範囲で変化させること
ができる。また生体活性無機材料のうちCaあるいは燐
酸を溶出しやすいものは新生骨の生成を助長し、より早
く固定化されるので有利である。生体活性無機材料より
なる層は前記ポーラス層上に汎用されている溶射法、蒸
着法あるいはスプレーパイロリシス法等により形成させ
る手段の他、ゾル−ゲル法を採用し成分調整したゾルを
ポーラス層に塗布した後ゲル(固体)層を形成させるこ
ともできる。しかし生体活性無機材料層の形成方法は何
ら制限されない。
Apatite-containing crystallized glass is a composite of crystals and glass, and the size, amount, or composition of the crystals can be changed continuously, and its properties can be changed over a wide range. Further, among bioactive inorganic materials, those that easily elute Ca or phosphoric acid are advantageous because they promote the formation of new bone and are fixed more quickly. The layer made of bioactive inorganic material can be formed on the porous layer by the commonly used thermal spraying method, vapor deposition method, spray pyrolysis method, etc., or by using a sol-gel method to form a sol with adjusted components on the porous layer. It is also possible to form a gel (solid) layer after application. However, the method of forming the bioactive inorganic material layer is not limited at all.

生体活性無機材料層とポーラス層を構成する素材間に大
きな熱膨張率差がある場合には、これらの物質の中間の
熱膨張率を有−する物質よりなる層を介在させることも
できる。当然この物質は無害でなくてはならない。この
ような物質としてジルコニアを含むガラスやジルコニア
を含むセラミックス等を挙げることができる。このよう
な中間層を設けることによって熱膨張率の差による生体
活性無機材料層の割れやポラース層からの剥離を抑制す
ることができる。
If there is a large difference in coefficient of thermal expansion between the materials constituting the bioactive inorganic material layer and the porous layer, a layer made of a material having a coefficient of thermal expansion intermediate between these materials may be interposed. Naturally, this substance must be harmless. Examples of such materials include glass containing zirconia and ceramics containing zirconia. By providing such an intermediate layer, cracking of the bioactive inorganic material layer and peeling from the porous layer due to a difference in coefficient of thermal expansion can be suppressed.

また代替骨1の形状は補填される自家骨欠損部の形状に
よって異なり。代替骨本体1°およびベース部材8もそ
れに合わせて形成される0代替骨本体1゛の貫通孔ある
いは凹部へのベース部材8の嵌着方法は特に限定されな
いが例えば下記(a)〜(f)に示すようにして行なう
ことができる[第2図(a)〜(f)参照]。
Further, the shape of the substitute bone 1 varies depending on the shape of the autologous bone defect to be compensated. The method of fitting the base member 8 into the through hole or recess of the substitute bone body 1' is not particularly limited, but for example, the following methods (a) to (f) are used. This can be carried out as shown in FIGS. 2(a) to 2(f).

(a)焼きばめまたは冷しばめ。(a) Shrink fit or cold fit.

(b)テーパー嵌合。(b) Tapered fit.

(C)ボルトおよびナツト止め。(C) Bolt and nut fastening.

(d)ビス止め。(d) Screw fastening.

(e)バネ止め:代替骨本体1°あるいはベース部材8
のいずれかにバネ付きピンを設けておき両者が嵌合した
ならばビンがバネの力で飛び出て両者°を固定する。
(e) Spring stop: substitute bone body 1° or base member 8
A spring-loaded pin is provided on one of the two, and when the two are fitted, the pin will pop out with the force of the spring, fixing the two.

(f)接着止め二代替骨本体1°とベース部材8間に接
着剤層9を設けて固定する。接着剤とじては前記ポリメ
チルメタクリレート、歯科用接合セメント、4メタレジ
ン等が挙げられる。
(f) Adhesive fixation An adhesive layer 9 is provided between the second alternative bone body 1° and the base member 8 for fixation. Examples of the adhesive include the above-mentioned polymethyl methacrylate, dental cement, and 4-metal resin.

本発明の代替骨は股関節をはじめ膝、肘、肩。The substitute bones of the present invention include hip joints, knees, elbows, and shoulders.

指などの関節用あるいはその他の長管骨用等の代替とし
であるいは人工歯根用などにも適用できる。
It can also be used as a substitute for joints such as fingers or other long bones, or for artificial tooth roots.

[実施例および比較例] 第1図(d)に示す代替骨本体(Ti−6AI −4■
チタン合金製股関節ステムの本体)1”に同組成よりな
るベース部材8を嵌着させ第1図(a)に示すような代
替骨(股関節ステム)1を得た。
[Example and Comparative Example] The substitute bone body (Ti-6AI-4■
A base member 8 made of the same composition was fitted onto a titanium alloy hip joint stem body 1" to obtain a substitute bone (hip joint stem) 1 as shown in FIG. 1(a).

尚ベース部材8には予め表面の一部に第1図(11)に
示すような300〜600μm径で同組成のチタン合金
粒体3を拡散接合し、さらにその上を生体活性無機材料
(第1表2番目の結晶化ガラス)6で被覆しておいた。
Incidentally, on a part of the surface of the base member 8, titanium alloy particles 3 having a diameter of 300 to 600 μm and the same composition as shown in FIG. It had been coated with crystallized glass (2nd crystallized glass in Table 1) 6.

これを犬の大腿骨に埋入したところ14日で歩ける程の
結合を示し、しかも長期に亘ってゆるみが生じてこなか
った。
When this was implanted into the femur of a dog, it showed enough bonding to allow walking in 14 days, and no loosening occurred over a long period of time.

一方ポーラス層のみを有し生体活性無機材料層を有しな
いステムを埋入したものは歩ける程の結合を形成するま
でに28日を要した。
On the other hand, when the stem was implanted with only a porous layer and no bioactive inorganic material layer, it took 28 days to form a bond that would allow walking.

[発明の効果] 本発明は以上のように構成されているので、本発明の代
替骨は自家骨に対して早期に結合し、時間とともに強固
に固定されていくので、長時間たフてもゆるみなどを生
ずることがない。
[Effects of the Invention] Since the present invention is configured as described above, the substitute bone of the present invention is quickly bonded to the autologous bone and is firmly fixed over time, so that it can be used for a long period of time. No loosening occurs.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図(a) 、 (b)および(c)は本発明に係る
代替骨の例(股関節ステム)を示す図であり、(d)は
その組立て構成例を示す図であり、(e) 、 (f)
 。 (g)および(h)はベース部材表層部の断面図、第2
図(a)〜(f)は代替骨本体とベース部材の嵌着方法
例を示す図、第3図(a) 、 (b)は従来の股関節
ステムの適用例を示す図、第4図(a) 、 (b)お
よび(c) 、 (d)は従来の代替骨の例(股関節ス
テム)とその表層部の断面図である。 1・・・代替骨(股関節ステム) 1°・・・代替骨本体(股関節ステム本体)2・・・自
家骨       3・・・粒体4・・・繊維    
    5・・・ポーラス層6・・・生体活性無機材料
  7・・・骨セメント8・・・ベース部材     
9・・・接着剤層第1図 (a)(b)(°) 第2図 第3図 (a)               (b)第4図
1(a), (b) and (c) are diagrams showing an example of the bone substitute (hip joint stem) according to the present invention, (d) is a diagram showing an example of its assembly configuration, and (e) , (f)
. (g) and (h) are cross-sectional views of the surface layer of the base member;
Figures (a) to (f) are diagrams showing an example of how to fit the substitute bone main body and the base member, Figures 3 (a) and (b) are diagrams showing an example of application of a conventional hip joint stem, and Figure 4 ( Figures a), (b), (c), and (d) are cross-sectional views of an example of a conventional bone substitute (hip stem) and its surface layer. 1...Substitute bone (hip stem) 1°...Substitute bone body (hip stem body) 2...Autologous bone 3...Grain 4...Fiber
5... Porous layer 6... Bioactive inorganic material 7... Bone cement 8... Base member
9... Adhesive layer Figure 1 (a) (b) (°) Figure 2 Figure 3 (a) (b) Figure 4

Claims (1)

【特許請求の範囲】[Claims] (1)骨欠損部補填用の代替骨において、該代替骨に形
成された貫通孔あるいは凹部にベース部材を嵌着させて
構成すると共に、前記ベース部材の残存自家骨との接触
側表面に生体活性無機材料によって被覆されているポー
ラス層が設けられていることを特徴とする代替骨。
(1) In a bone substitute for filling a bone defect, a base member is fitted into a through hole or a recess formed in the substitute bone, and a surface of the base member in contact with the remaining autologous bone is provided with a living body. A bone substitute characterized in that it is provided with a porous layer coated with an active inorganic material.
JP63050280A 1988-03-02 1988-03-02 Substitute bone Pending JPH01223970A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63050280A JPH01223970A (en) 1988-03-02 1988-03-02 Substitute bone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63050280A JPH01223970A (en) 1988-03-02 1988-03-02 Substitute bone

Publications (1)

Publication Number Publication Date
JPH01223970A true JPH01223970A (en) 1989-09-07

Family

ID=12854518

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63050280A Pending JPH01223970A (en) 1988-03-02 1988-03-02 Substitute bone

Country Status (1)

Country Link
JP (1) JPH01223970A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016514514A (en) * 2013-03-21 2016-05-23 シファメド・ホールディングス・エルエルシー Adjustable intraocular lens
US10195018B2 (en) 2013-03-21 2019-02-05 Shifamed Holdings, Llc Accommodating intraocular lens
US10350057B2 (en) 2013-02-14 2019-07-16 Shifamed Holdings, Llc Hydrophilic AIOL with bonding
US10350056B2 (en) 2016-12-23 2019-07-16 Shifamed Holdings, Llc Multi-piece accommodating intraocular lenses and methods for making and using same
US10736734B2 (en) 2014-08-26 2020-08-11 Shifamed Holdings, Llc Accommodating intraocular lens
US10987214B2 (en) 2017-05-30 2021-04-27 Shifamed Holdings, Llc Surface treatments for accommodating intraocular lenses and associated methods and devices
US11141263B2 (en) 2015-11-18 2021-10-12 Shifamed Holdings, Llc Multi-piece accommodating intraocular lens
US11266496B2 (en) 2017-06-07 2022-03-08 Shifamed Holdings, Llc Adjustable optical power intraocular lenses

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10350057B2 (en) 2013-02-14 2019-07-16 Shifamed Holdings, Llc Hydrophilic AIOL with bonding
US10709549B2 (en) 2013-02-14 2020-07-14 Shifamed Holdings, Llc Hydrophilic AIOL with bonding
US11540916B2 (en) 2013-02-14 2023-01-03 Shifamed Holdings, Llc Accommodating intraocular lens
JP2016514514A (en) * 2013-03-21 2016-05-23 シファメド・ホールディングス・エルエルシー Adjustable intraocular lens
US10195018B2 (en) 2013-03-21 2019-02-05 Shifamed Holdings, Llc Accommodating intraocular lens
US10548718B2 (en) 2013-03-21 2020-02-04 Shifamed Holdings, Llc Accommodating intraocular lens
US11583390B2 (en) 2014-08-26 2023-02-21 Shifamed Holdings, Llc Accommodating intraocular lens
US10736734B2 (en) 2014-08-26 2020-08-11 Shifamed Holdings, Llc Accommodating intraocular lens
US11141263B2 (en) 2015-11-18 2021-10-12 Shifamed Holdings, Llc Multi-piece accommodating intraocular lens
US11065109B2 (en) 2016-12-23 2021-07-20 Shifamed Holdings, Llc Multi-piece accommodating intraocular lenses and methods for making and using same
US10350056B2 (en) 2016-12-23 2019-07-16 Shifamed Holdings, Llc Multi-piece accommodating intraocular lenses and methods for making and using same
US10987214B2 (en) 2017-05-30 2021-04-27 Shifamed Holdings, Llc Surface treatments for accommodating intraocular lenses and associated methods and devices
US11266496B2 (en) 2017-06-07 2022-03-08 Shifamed Holdings, Llc Adjustable optical power intraocular lenses

Similar Documents

Publication Publication Date Title
FI78232B (en) IMPLANTS, SOM ERSAETTER EN TAND ELLER EN DEL AV BENVAEVNADEN MED SYNTETISKT MATERIAL.
KR880001652B1 (en) Implant and method for production thereof
US4702930A (en) Method of producing implantable bone replacement materials
Jansen et al. Histologic evaluation of the osseous adaptation to titanium and hydroxyapatite‐coated titanium implants
KR100655170B1 (en) Artificial joint system
US5947893A (en) Method of making a porous prothesis with biodegradable coatings
US4871578A (en) Hydroxylapatite coating on metal or ceramic
JP2858126B2 (en) Biological implant material and its manufacturing method
Yang et al. In vitro and in vivo mechanical evaluations of plasma‐sprayed hydroxyapatite coatings on titanium implants: The effect of coating characteristics
Wang et al. Interfacial shear strength and histology of plasma sprayed and sintered hydroxyapatite implants in vivo
Heimke Tissue interactions to bone replacement materials
JPH01223970A (en) Substitute bone
JP2761339B2 (en) Novel surface coating for prosthetic devices and prosthetic devices coated thereby
US5217496A (en) Implant and method of making it
Driskell¹ Early history of calcium phosphate materials and coatings
JPH04242659A (en) Vivi-implant material and manufacture thereof
Kay Designing to counteract the effects of initial device instability: materials and engineering
JPH01212551A (en) Artificial bone
Wolke et al. Bioceramics for maxillofacial applications
Savich PM Applications: Powder Metallurgy Technology in Production of Medical Implants. Why?
JP2997809B2 (en) Biological implant components
JPH01265954A (en) Substitute bone
JP4549016B2 (en) Biomaterial
JPH01265955A (en) Living bone affinity member and substitute bone with this member in conjugation
Ishikawa et al. Effect of hydroxyapatite containing glass coating on the bonding between bone and titanium implants